TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 22572022

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1 mA for 20 min) during 30 min of conventional swallowing training for 10 days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sham tDCS (1 mA for 30 s) during 30 min of conventional swallowing training for 10 days
Number of subjects: 16
Study: 19247842

Group type: EXPERIMENTAL
Intervention: Low dose of IPP and VPP peptides
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Medium dose of IPP and VPP peptides
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: High dose of IPP and VPP peptides
Number of subjects: 166

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 166
Study: 17120252

Group type: EXPERIMENTAL
Intervention: Intraoperative hypothermia (t = 33 degrees C)
Number of subjects: 1001

Group type: COMPARATOR
Intervention: Normothermia (37 degrees C)
Number of subjects: 1001
Study: 15657667

Group type: EXPERIMENTAL
Intervention: High-viscosity stool substitute
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-viscosity oil with placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oil with orlistat
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Stool substitute with free fatty acid
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High-viscosity enemas
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-viscosity enemas
Number of subjects: 10
Study: 11706093

Group type: EXPERIMENTAL
Intervention: beta-interferon-1a (betaINF1a) administered IM once a week at a dose of 30 microg for 24 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 9202923

Group type: EXPERIMENTAL
Intervention: TOF-RB
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: DBS-RB
Number of subjects: 100

Group type: COMPARATOR
Intervention: TOF-control
Number of subjects: 100

Group type: COMPARATOR
Intervention: DBS-control
Number of subjects: 100
Study: 7619105

Group type: EXPERIMENTAL
Intervention: 300 mg Ca/d as calcium carbonate
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 162
Study: 2908803

Group type: EXPERIMENTAL
Intervention: 15 mg of ketazolam daily for 15 days
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: 15 mg of ketazolam continued for a further 15 days for responders
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo continued for a further 15 days for non-responders
Number of subjects: 63
Study: 31996189

Group type: EXPERIMENTAL
Intervention: Social franchise CBCT with community members as counsellors
Number of subjects: 100

Group type: COMPARATOR
Intervention: Full-time employed HIV counsellors conducting CBCT
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Social franchise CBCT
Number of subjects: 100

Group type: COMPARATOR
Intervention: Full-time employed HIV counsellors
Number of subjects: 100
Study: 30900575

Group type: EXPERIMENTAL
Intervention: Oral azithromycin (1.25 g for 5 days)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Oral doxycycline (4 g for 30 days)
Number of subjects: 115
Study: 28738862

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (rIPC) - induced by inflating a blood pressure cuff placed on the upper arm three times for 5 minutes at 200 mmHg after induction of anesthesia.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group - no preconditioning performed.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (rIPC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 25097137

Group type: EXPERIMENTAL
Intervention: Model-Based Iterative Reconstruction (MBIR)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Adaptive Statistical Iterative Reconstruction (ASiR)
Number of subjects: 100
Study: 22865266

Group type: EXPERIMENTAL
Intervention: Sipuleucel-T
Number of subjects: 737
Study: 21985258

Group type: EXPERIMENTAL
Intervention: Cognitive group therapy (CGT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Focused psychodynamic group therapy (FGT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 0
Study: 17674003

Group type: EXPERIMENTAL
Intervention: 1.25-mm prospective scan
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 2.5-mm prospective scan
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 2.5-mm overlapping retrospective scans
Number of subjects: 100
Study: 15310353

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 0

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 0
Study: 11779591

Group type: EXPERIMENTAL
Intervention: Cyproterone acetate 12.5 mg/d for 6 months
Number of subjects: 90

Group type: COMPARATOR
Intervention: Oral contraceptive (ethinyl estradiol 0.02 mg and desogestrel 0.15 mg) for 6 months
Number of subjects: 90
Study: 9521247

Group type: EXPERIMENTAL
Intervention: Streptokinase (SK, 1.5 million IU I.V.)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 7862792

Group type: EXPERIMENTAL
Intervention: Alexithymic students
Number of subjects: 215
Study: 2680085

Group type: EXPERIMENTAL
Intervention: Cimetidine 800 mg once daily at bedtime for six weeks
Number of subjects: 163

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study: 785563

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 and Placebo
Number of subjects: 18
Study: 31166952

Group type: EXPERIMENTAL
Intervention: Biannual oral azithromycin (20mg/kg for children, 1 g for adults)
Number of subjects: 455

Group type: COMPARATOR
Intervention: No programmatic antibiotics (control group)
Number of subjects: 455
Study: 27289068

Group type: EXPERIMENTAL
Intervention: Active Music Engagement (AME + P)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 16
Study: 26122078

Group type: EXPERIMENTAL
Intervention: Health warnings of smoking based on a specially designed leaflet and patient-centred counseling from nurse counselors with emphasis on risk perceptions of smoking to cancer prognosis, plus two telephone counseling sessions at 1-week and 1-month.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care and a generic self-help smoking cessation booklet.
Number of subjects: 0
Study: 23158886

Group type: EXPERIMENTAL
Intervention: Sequential treatment for 14 days (S-14)
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Sequential treatment for 10 days (S-10)
Number of subjects: 900

Group type: COMPARATOR
Intervention: Triple therapy for 14 days (T-14)
Number of subjects: 900
Study: 22205452

Group type: EXPERIMENTAL
Intervention: Fiberform granule for 2 weeks
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group (no medication)
Number of subjects: 121
Study: 19932846

Group type: EXPERIMENTAL
Intervention: EJV preservation
Number of subjects: 38

Group type: COMPARATOR
Intervention: EJV sacrifice
Number of subjects: 38
Study: 16945895

Group type: EXPERIMENTAL
Intervention: Total-etching system (Etch 37 with One Step Plus)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Self-etching system (Tyrian SPE with One Step Plus)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Orthotropic fiber-reinforced composite (FRC) at the interface
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Enamel bonding
Number of subjects: 10

Group type: COMPARATOR
Intervention: Dentin bonding
Number of subjects: 10
Study: 15237267

Group type: COMPARATOR
Intervention: Meglumine antimoniate (MA)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Zinc sulfate (ZS) 2%
Number of subjects: 104
Study: 11408326

Group type: EXPERIMENTAL
Intervention: Cochlear implant patients
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal hearing controls
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 9425674

Group type: EXPERIMENTAL
Intervention: Better instances of the vowel /i/
Number of subjects: 0

Group type: COMPARATOR
Intervention: Materials based on Kuhl's tokens of /i/
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vowels developed from Kuhl's test set
Number of subjects: 0
Study: 8514613

Group type: EXPERIMENTAL
Intervention: ACT group (20 mg/m2 adriamycin i.v. on days 1 and 8, 100 mg cyclophosphamide p.o. on days 1-14, 20 mg tamoxifen p.o. daily)
Number of subjects: 82

Group type: COMPARATOR
Intervention: ACM group (20 mg/m2 adriamycin i.v. on days 1 and 8, 100 mg cyclophosphamide p.o. on days 1-14, 1200 mg medroxyprogesterone acetate p.o. daily)
Number of subjects: 82
Study: 3651272

Group type: EXPERIMENTAL
Intervention: Dideco Autotrans BT 795 autotransfusion device
Number of subjects: 41
Study: 29242108

Group type: EXPERIMENTAL
Intervention: Access Only arm (discount, fresh F&V markets)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Access Plus arm (markets plus educational components)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison (attention placebo intervention on physical activity and stress reduction)
Number of subjects: 0
Study: 27088277

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (PBM) using a neodymium-doped yttrium aluminum garnet (Nd:YAG) laser (1064 nm), applied immediately after surgery and every 24 hours for 4 days.
Number of subjects: 30

Group type: COMPARATOR
Intervention: PBM sham (control group)
Number of subjects: 30
Study: 25688495

Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg once daily
Number of subjects: 123

Group type: COMPARATOR
Intervention: Exemestane 25 mg once daily
Number of subjects: 123
Study: 22171781

Group type: COMPARATOR
Intervention: Radiant warmer (group R)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Warm cotton blankets (group B)
Number of subjects: 130
Study: 20425656

Group type: EXPERIMENTAL
Intervention: Memory enhancement condition
Number of subjects: 53
Study: 18673544

Group type: EXPERIMENTAL
Intervention: Ethnicity-based risk score
Number of subjects: 1415

Group type: COMPARATOR
Intervention: Age-based selection
Number of subjects: 1415

Group type: EXPERIMENTAL
Intervention: Prevalence of DM
Number of subjects: 1415
Study: 17133471

Group type: EXPERIMENTAL
Intervention: Pegylated interferon‐alpha‐2a and ribavirin
Number of subjects: 173
Study: 12175452

Group type: EXPERIMENTAL
Intervention: Mint nicotine gum
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Original nicotine gum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amphetamine (positive control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Confectionery gum (positive control)
Number of subjects: 0
Study: 10439886

Group type: EXPERIMENTAL
Intervention: Digitoxin (N = 8)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Trichlormethiazide/amiloride (N = 8)
Number of subjects: 16
Study: 7876852

Group type: EXPERIMENTAL
Intervention: TRH analogue (RX77368)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 2222277

Group type: EXPERIMENTAL
Intervention: Botulinum toxin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Adjustable suture surgery
Number of subjects: 30
Study: 18491

Group type: EXPERIMENTAL
Intervention: SCH 16134 (new benzodiazepine hypnotic)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31446189

Group type: EXPERIMENTAL
Intervention: Tumor deposits
Number of subjects: 9246

Group type: EXPERIMENTAL
Intervention: Both tumor deposits and lymph node metastases
Number of subjects: 9246

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting overall survival
Number of subjects: 9246
Study: 30952212

Group type: EXPERIMENTAL
Intervention: Insomnia disorder (diagnosed using ICSD-2 criteria)
Number of subjects: 4717

Group type: EXPERIMENTAL
Intervention: Younger age categories
Number of subjects: 4717

Group type: EXPERIMENTAL
Intervention: Worse self-rated health
Number of subjects: 4717

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 4717
Study: 28359716

Group type: EXPERIMENTAL
Intervention: O-3FA ethyl esters (750 mg/d DHA and 1860 mg/d EPA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard statin therapy
Number of subjects: 100
Study: 26171113

Group type: EXPERIMENTAL
Intervention: DEX (group D)
Number of subjects: 60

Group type: COMPARATOR
Intervention: midazolam (group M)
Number of subjects: 60
Study: 23200601

Group type: EXPERIMENTAL
Intervention: 6-week group exercise and self-management programme facilitated by a physiotherapist in primary care
Number of subjects: 352

Group type: COMPARATOR
Intervention: Standard GP care
Number of subjects: 352
Study: 22199129

Group type: EXPERIMENTAL
Intervention: Dietary supplementation with fish oil (783 mg DHA, 162 mg EPA), bilberry extract (59 mg anthocyanidin), and lutein (17.5 mg) for 4 weeks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dietary supplementation with fish oil, bilberry extract, and lutein
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo capsules for 4 weeks
Number of subjects: 20
Study: 19670077

Group type: EXPERIMENTAL
Intervention: Carbon dioxide (CO2) insufflation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 30
Study: 16686608

Group type: EXPERIMENTAL
Intervention: 5% permethrin cream
Number of subjects: 106
Study: 15383019

Group type: EXPERIMENTAL
Intervention: 100 mg of iron(II) daily (Group A after first three donations)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: 100 mg of iron(II) daily (Group B after second three donations)
Number of subjects: 260

Group type: COMPARATOR
Intervention: Placebo (both treatment groups during placebo phase)
Number of subjects: 260
Study: 11296070

Group type: EXPERIMENTAL
Intervention: Piracetam therapy (80‐100 mg/kg per day)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Piracetam therapy
Number of subjects: 25
Study: 11009193

Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8796815

Group type: EXPERIMENTAL
Intervention: Naloxone 1 or 4 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Naloxone (both doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Estradiol, progesterone, and prolactin concentrations
Number of subjects: 0
Study: 1537026

Group type: EXPERIMENTAL
Intervention: Glaxo strain of BCG
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Pasteur strain of BCG
Number of subjects: 21
Study: 6147080

Group type: EXPERIMENTAL
Intervention: Bucindolol
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Combination of Bucindolol and Hydrochlorothiazide
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 29953055

Group type: EXPERIMENTAL
Intervention: Tonsilgon-N (25 droplets thrice daily for 30 days) combined with 10 sessions of lagune cleansing using Tonsillor apparatus for 30 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group with only 10 sessions of rinsing the palatine tonsil lagunes
Number of subjects: 60
Study: 27238057

Group type: EXPERIMENTAL
Intervention: Idebenone (900 mg/day)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Idebenone
Number of subjects: 64
Study: 24576440

Group type: EXPERIMENTAL
Intervention: Local application of dexamethasone 4 mg/1 mL on the inferior alveolar nerve during BSSO surgery
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control side (no dexamethasone applied)
Number of subjects: 18
Study: 21474320

Group type: EXPERIMENTAL
Intervention: Esmarch bandage exsanguination (Group A)
Number of subjects: 38

Group type: COMPARATOR
Intervention: No Esmarch bandage exsanguination (Group B)
Number of subjects: 38
Study: 20080545

Group type: EXPERIMENTAL
Intervention: Tailor-made notched music treatment
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo notched music treatment
Number of subjects: 8
Study: 17490472

Group type: EXPERIMENTAL
Intervention: First-generation antipsychotic medication
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second-generation antipsychotic medication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall cognitive performance
Number of subjects: 0
Study: 16350770

Group type: EXPERIMENTAL
Intervention: Brief interventions for alcohol misuse; characterized by low intensity and short duration (5-60 minutes).
Number of subjects: 0
Study: 12410072

Group type: EXPERIMENTAL
Intervention: Experimental (EXP) delivery of methylphenidate (MPH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thrice-daily (TID) regimen of methylphenidate (MPH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 0
Study: 9704788

Group type: EXPERIMENTAL
Intervention: 5-color fluorescent in situ hybridization analysis on flow-sorted cells for chromosomes X, Y, 13, 18, and 21
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 5-color fluorescent in situ hybridization analysis
Number of subjects: 40
Study: 7889635

Group type: EXPERIMENTAL
Intervention: GH treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 1974206

Group type: EXPERIMENTAL
Intervention: epanolol 200 mg daily for 7 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study: 31627252

Group type: EXPERIMENTAL
Intervention: PCL for DSM‐IV (the PCL‐C)
Number of subjects: 1003

Group type: EXPERIMENTAL
Intervention: Predicted PCL‐5 scores
Number of subjects: 1003

Group type: EXPERIMENTAL
Intervention: Crosswalk's accuracy
Number of subjects: 1003
Study: 29398646

Group type: EXPERIMENTAL
Intervention: Submergence-tolerant genotypes (Binadhan-11, Binadhan-12, RC 249, RC 251)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Moderately tolerant genotypes (RC 192, RC 193, RC 225)
Number of subjects: 10

Group type: COMPARATOR
Intervention: All genotypes under submergence stress
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Days to flowering
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Plant height
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Molecular characterization with SSR markers (RM 24, SC3, SUB1)
Number of subjects: 10
Study: 26823503

Group type: EXPERIMENTAL
Intervention: Complete resection of contrast-enhancing tumor (N = 40)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Residual detection of contrast enhancement (N = 19)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Surgery at first recurrence
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Incomplete tumor resection
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Quality of life assessment
Number of subjects: 105
Study: 24161568

Group type: EXPERIMENTAL
Intervention: Hypofractionation (HYPO) - 63 Gy/28 fractions for T1 and 67.5 Gy/30 fractions for T2
Number of subjects: 156

Group type: COMPARATOR
Intervention: Conventional fractionation (CONV) - 66 Gy/33 fractions for T1 and 70 Gy/35 fractions for T2
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Hypofractionation (HYPO) for T1a disease
Number of subjects: 156

Group type: COMPARATOR
Intervention: Conventional fractionation (CONV) for T1a disease
Number of subjects: 156
Study: 22304887

Group type: EXPERIMENTAL
Intervention: 8-day intensive treatment for panic disorder (PDA)
Number of subjects: 0
Study: 19171717

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILS)
Number of subjects: 3234

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 3234

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3234
Study: 18940490

Group type: EXPERIMENTAL
Intervention: Clonidine associated to remifentanil
Number of subjects: 20

Group type: COMPARATOR
Intervention: Dexmedetomidine associated to isoflurane
Number of subjects: 20
Study: 16091146

Group type: EXPERIMENTAL
Intervention: Apple Juice (AJ) 15 ml/kg twice daily
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: White Grape Juice (WGJ) 15 ml/kg twice daily
Number of subjects: 90

Group type: COMPARATOR
Intervention: Colored and flavored water (WA)
Number of subjects: 90
Study: 12444941

Group type: EXPERIMENTAL
Intervention: HAART (including indinavir, ritonavir, RTV/saquinavir)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: RTV or RTV/SQV
Number of subjects: 168
Study: 10702653

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg titrated to Losartan 50 mg/Hydrochlorothiazide (HCT) 12.5 mg (n = 11)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg titrated to 10 mg (n = 14)
Number of subjects: 25
Study: 8590958

Group type: EXPERIMENTAL
Intervention: GHRH‐antagonist (100 micrograms/100 ml saline over 75 min) administered in the morning
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: GHRH‐antagonist (100 micrograms/100 ml saline over 75 min) administered in the evening
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (physiological fluctuations in plasma GH)
Number of subjects: 14
Study: 1717206

Group type: EXPERIMENTAL
Intervention: solution enriched with branched chain amino acid (45% BCAA)
Number of subjects: 27

Group type: COMPARATOR
Intervention: balanced amino acid solution (24% BCAA)
Number of subjects: 27

Group type: COMPARATOR
Intervention: dextrose
Number of subjects: 27
Study: 6184569

Group type: EXPERIMENTAL
Intervention: Verapamil (160 mg thrice daily)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Nifedipine (20 mg slow release twice daily)
Number of subjects: 28
Study: 30287324

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 26
Study: 27816732

Group type: EXPERIMENTAL
Intervention: Gastric aspiration performed after orthognathic surgery
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no gastric aspiration)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Gastric aspiration
Number of subjects: 24
Study: 26208989

Group type: EXPERIMENTAL
Intervention: Patients' subjective rating of mental health improvement from baseline to week 12
Number of subjects: 0

Group type: COMPARATOR
Intervention: Objective improvement on the PANSS
Number of subjects: 0
Study: 23841976

Group type: EXPERIMENTAL
Intervention: Kinesio Tape applied to hand and forearm for 6 days in combination with standard therapy
Number of subjects: 17

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 17
Study: 21349365

Group type: EXPERIMENTAL
Intervention: Trivalent Inactivated Vaccine (TIV)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Two doses of TIV
Number of subjects: 148